Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

AZTR

AMEX:AZTR

Azitra, Inc.

Last Close

1.14

26/07 20:00

Market Cap

1.09M

Beta: -

Volume Today

2.14M

Avg: 26.53K

PE Ratio

−0.90

PFCF: −1.60

locale

market

website

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics